Google Scholar | Citations: 16429| h-index: 32 | i10-index: 482
Evaluation of the hypoglycemiating effect of Bauhinia forficata (pata-de-vaca) and its applicability in the treatment of diabetes mellitus type II
PDF (Portuguese (Brazil))

Keywords

Medicinal plants
Diabetes Mellitus
Hypoglycemic
Ethnopharmacology

How to Cite

Evaluation of the hypoglycemiating effect of Bauhinia forficata (pata-de-vaca) and its applicability in the treatment of diabetes mellitus type II. (2022). Electronic Journal Collection Health, 15(2), e9645. https://doi.org/10.25248/reas.e9645.2022

Copyright © | All rights reserved.

The journal holds the exclusive copyright for the publication of this article under the terms of Brazilian law 9610/98.

Partial reproduction
The use of parts of the texts, figures and questionnaire of the article is free, being mandatory the citation of the authors and journal.

Total reproduction
It is expressly prohibited and must be authorized by the journal.

Abstract

Objective: To carry out a literature review about the hypoglycemic effects of Bauhinia forficata (pata-de-vaca) and its applicability in the treatment of type II diabetes mellitus. Methods: This is a cross-sectional, exploratory, qualitative and descriptive study, based on the scientific databases: Medline via PubMed, Science Direct and Google Scholar, using the descriptors “Bauhinia forficata” and “Diabetes”, in the time frame. from 2017 to 2021. The titles and abstracts of the articles found were read and nine (n=9) articles were selected that contained experimental procedures for evaluating the hypoglycemic action of cow's foot and application in the treatment of type II diabetes. Results: Scientific evidence proves the presence of flavonoids responsible for the hypoglycemic activity of Bauhinia forficata, resulting in the reduction of serum glucose levels, in different concentrations of the medicinal plant and pharmaceutical forms. Final considerations: That Bauhinia forficata has a beneficial action on the reduction of glucose in the body, is safe in use, is accessible and economically viable, and can be used as a complementary treatment for type II diabetes mellitus, provided that its use is rational. and guided by health professionals.

PDF (Portuguese (Brazil))